Talis Biomedical Corporat... (TLIS)
1.55
-0.01 (-0.64%)
At close: Jan 14, 2025, 8:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 412.00K | 3.65M | n/a | 10.94M | 3.98M | 2.39M |
| Cost of Revenue | 41.00K | 8.39M | 2.62M | n/a | n/a | n/a |
| Gross Profit | 371.00K | -4.74M | -2.62M | 10.94M | 3.98M | 2.39M |
| Operating Income | -66.81M | -115.14M | -191.82M | -91.18M | -26.70M | -21.43M |
| Interest Income | n/a | n/a | n/a | 54.00K | 42.00K | 93.00K |
| Pretax Income | -62.01M | -113.01M | -192.04M | -91.13M | -27.47M | -21.34M |
| Net Income | -62.01M | -110.89M | -190.46M | -91.08M | -27.43M | -21.34M |
| Selling & General & Admin | 28.21M | 40.73M | 42.42M | 13.10M | 6.86M | 5.43M |
| Research & Development | 40.69M | 70.83M | 157.59M | 89.02M | 23.81M | 18.39M |
| Other Expenses | -1.72M | -1.16M | -8.19M | -10.94M | -3.98M | n/a |
| Operating Expenses | 67.19M | 110.40M | 191.82M | 91.18M | 26.70M | 21.43M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 67.23M | 118.79M | 191.82M | 91.18M | 26.70M | 21.43M |
| Income Tax | n/a | -2.13M | -1.58M | -54.00K | -42.00K | 93.00K |
| Shares Outstanding (Basic) | 1.82M | 1.78M | 1.51M | 290.00K | 150.00K | 150.42K |
| Shares Outstanding (Diluted) | 1.82M | 1.78M | 1.51M | 290.00K | 150.00K | 150.42K |
| EPS (Basic) | -34.12 | -62.45 | -126.13 | -314.06 | -182.88 | -141.85 |
| EPS (Diluted) | -34.12 | -62.45 | -126.13 | -314.06 | -182.88 | -141.85 |
| EBITDA | -66.05M | -106.31M | -191.82M | -90.42M | -25.97M | -20.78M |
| Depreciation & Amortization | 770.00K | 11.60M | 2.62M | 1.37M | 726.00K | 647.00K |